Välkomna till ett medlemsexklusivt webinar med Chloé Pronovost-Morgan (MSc) med fokus på placeboeffekten samt set & setting i klinisk psykedelisk forskning.

Zoomlänk till webinaret läggs ut på våra medlemskanaler i god tid inför evenemanget. Läs mer och bli medlem på www.npv.se

- Talk Description -
The placebo effect is one of the most robust and replicated phenomena in clinical research. Yet, the idea of leveraging the placebo effect for patient benefits remains controversial. In this webinar, we will delve into the historical origins of “the placebo”, both in clinical practice and research, challenging some of the assumptions that have contributed to its pejorative connotations and suboptimal handling in research. We will also examine the relationship between the placebo effect and the concept of 'set and setting' in psychedelic science, highlighting the paradigmatic tensions between the biomedical ‘additive’ model and the psychedelic 'interactive' model. Finally, we will discuss how both fields could benefit from enhanced documentation and reporting of extra-pharmacological variables, to overcome shortcomings in current research designs.

- Bio -
Chloé Pronovost-Morgan is a researcher and medical student with a strong interest in extra-pharmacological determinants of therapeutic outcomes. She holds and MSc in Cognitive and Clinical Neuroscience from Maastricht University, and a BA in honours Psychology from McGill University. As part of her masters, she interned at Imperial College London’s Centre for Psychedelic Research, where she launched 'The Delphi Study on Setting' under the supervision of Dr. Leor Roseman and Dr. Kyle Greenway - an international expert consensus study that generated guidelines for reporting setting variables in psychedelic clinical trials (currently under review). She is now back in Montreal, her hometown, to complete her medical degree at McGill University with the aim of becoming of clinician-scientist in psychiatry.